EXHIBIT
32.2
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350
AS
ADOPTED PURSUANT TO SECTION 906 OF
THE
SARBANES-OXLEY ACT OF 2002
The
certification set forth below is hereby made solely for the purpose of
satisfying the requirements of Section 906 of the Sarbanes-Oxley Act of 2002
and
may not be relied upon or used for any other purposes.
In
connection with the Quarterly Report of Access Pharmaceuticals, Inc. (the
“Company”) on Form 10-QSB for the period ended June 30, 2007, as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), I, Stephen
B. Thompson, Chief Financial Officer certify pursuant to 18 U.S.C. 1350, as
adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002, that (1)
the
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934 and (2) the information contained in the Report
fairly presents, in all material respects, the financial condition and results
of operations of the Company.
A
signed
original of this written statement required by Section 906 or other document
authenticating, acknowledging or otherwise adopting the signature that appears
in typed form within the electronic version of this written statement required
by Section 906 has been provided to the Company and will be retained by the
Company and furnished to the Securities and Exchange Commission or its staff
upon request.
Signed
at
the City of Dallas, in the State of Texas, this 14th day of August,
2007.
/s/
Stephen B. Thompson
Stephen
B. Thompson
Chief
Financial Officer